Impact of Infection‐Related Immune Responses on ANCA‐Associated Vasculitis in Finns: A Mendelian Randomization Study
Genetics Research · 2026-01 · 2026 (1)
DOI: 10.1155/genr/3406375 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genetics Research, online erschienen am 23.08.2026. Verfasst von Naidan Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Peoples Hospital of Deyang City, Deyang 618000, Sichuan, China, scu.edu.cn. Hauptthemen laut MEDLINE: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chengdu University of Traditional Chinese Medicine.
Abstract (Originalsprache)
Background
ANCA‐associated vasculitis (AAV) includes microscopic polyarteritis (MPA), granulomatosis with polyangiitis (GPA), and eosinophilic granulomatosis with polyangiitis (EGPA). Studies have revealed that infection‐related immune responses could trigger vasculitis. This study aims to investigate the relationship between infection‐related immune responses and AAV in Finns.
Methods
We used multiple Mendelian randomization (MR) methods and bioinformatics to examine how infection‐related immune responses affect AAV, also investigating the mediation effects of neutrophil extracellular traps (NETs) and aging phenotypes. Bioinformatics data were from the Gene Expression Omnibus (GEO) database. Serum‐specific antibodies were from the U.K. Biobank. AAV subtypes were from FinnGen. Single‐cell sequencing data of immune cells were from the OneK1K database. NETs and aging phenotypes were from the genome‐wide association studies (GWAS).
Results
This study found a preliminary negative correlation between anti‐IgG of HSV1 and the risk of MPA (OR: 0.499, 95% CI: 0.361–0.692, p = 3.05E‐05). The SCeQTL analysis revealed that several genes in immune cells were linked to anti‐IgG of HSV1 and MPA, while mediation analysis highlighted DNA methylation Hannum age acceleration (DNAmAA) as a key mediator between gene expression and MPA. HLA‐C expression in CD8nc T cells ( Z = −2.921, p = 0.003, mediation effect = 82.2%) and MDC1 in dendritic cells ( Z = −3.310, p = 0.001, mediation effect = 81.5%) lowered the risk of MPA by downregulating DNAmAA. Conversely, MICA expression in NKR NK cells ( Z = 3.702, p < 0.001, mediation effect = 72.1%) was associated with an increased risk of MPA by upregulating DNAmAA.
Conclusions
This study demonstrated potential correlations between infection‐related immune responses and MPA. The SCeQTL analysis revealed that HLA‐C expression in CD8nc T cells, MDC1 in dendritic cells, and MICA expression in NKR cells were related to the risk of MPA. Furthermore, mediation analysis indicated that DNAmAA exerted a strong mediation effect on the relationship between gene expression and MPA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Peoples Hospital of Deyang City, Deyang 618000, Sichuan, China, scu.edu.cn.
- Department of Rheumatology, Peoples Hospital of Deyang City, Deyang 618000, Sichuan, China, scu.edu.cn.
ORCID-Profile: Naidan Zhang, Caixia Ji, Tong Lv, Xiao Bao
Förderung
- Chengdu University of Traditional Chinese Medicine
Zitieren
APA
Zhang, N., Ji, C., Lv, T., & Bao, X. (2026). Impact of Infection‐Related Immune Responses on ANCA‐Associated Vasculitis in Finns: A Mendelian Randomization Study. Genetics Research, 2026(1). https://doi.org/10.1155/genr/3406375
Vancouver
Zhang N, Ji C, Lv T, Bao X. Impact of Infection‐Related Immune Responses on ANCA‐Associated Vasculitis in Finns: A Mendelian Randomization Study. Genetics Research. 2026;2026(1). doi:10.1155/genr/3406375
BibTeX
@article{Zhang2026,
author = {Zhang, Naidan and Ji, Caixia and Lv, Tong and Bao, Xiao},
title = {Impact of Infection‐Related Immune Responses on ANCA‐Associated Vasculitis in Finns: A Mendelian Randomization Study},
journal = {Genetics Research},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/genr/3406375}
}
EUVIMED